分享此文章： Share on Email Share on Line Share on Facebook Copy to Clipboard Previous Post PrecisemAb Awarded the Title of “2025 Emerging High-Potential Startup” Next Post PrecisemAb Successfully Develops Universal Antibody Lock to Overcome the Trade Off Between Efficacy and Toxicity in Cancer Therapy
Get In Touch We can't wait to hear from you！ Contact Us +886 7 311 1577 ｜Taipei office｜ 17F, No. 3, Park St., Nangang Dist., Taipei City 115, Taiwan Kaohsiung office｜ 12F, 1st Teaching Building, 100, Shih-Chuan 1st Rd., Sanmin Dist., Kaohsiung 807, Taiwan Home About Technical Capabilities Pipeline Antibody LockTM Platform News Partner & Investor Contact Stay Connected If you see this, Happy New Year! If you see this, Happy New Year!
